Physiologically Based Biopharmaceutics Model of Vildagliptin Modified Release (MR) Tablets to Predict In Vivo Performance and Establish Clinically Relevant Dissolution Specifications.
- Resource Type
- Article
- Source
- AAPS PharmSciTech; May2022, Vol. 23 Issue 4, p1-17, 17p
- Subject
- Language
- ISSN
- 15309932